Literature DB >> 34370500

The effect of area-level disadvantage and race on smoking abstinence in a clinical trial.

Nicole L Nollen1, Matthew S Mayo2, Jarron M Saint Onge1, Taneisha S Scheuermann1, Lisa Sanderson Cox1, David Chae3, Eleanor Leavens1, Jasjit S Ahluwalia4.   

Abstract

Reasons for Black-White disparities in smoking abstinence are not well understood. This study examined area-level socioeconomic disadvantage as a contributor to lower quit rates for Blacks who smoke among 223 Black and 221 White low-income individuals who smoke enrolled in a smoking cessation trial. Outcome was cotinine-verified abstinence at week 26. Census tract-level disadvantage was measured using 5-year estimates linked to participants' home address and included percentage of: female headed households; public assistance; unemployed; < 100% of the federal poverty level; and whether there was > 25% having less than a high school education. A neighborhood disadvantage index score (DIS) was calculated as the sum of z scores for each variable. Black participants lived in more disadvantaged areas than White participants [DIS mean (SD): 3.2 (4.3), -1.0 (3.2), p < .001]. Similar rates of abstinence were observed at the same level of disadvantage [DIS ≥ 50th percentile (less disadvantage): 21.9% Blacks, 26.2% Whites, p = .50; DIS < 50th percentile (more disadvantage): 10.7% Blacks, 15.8% Whites, p = .31]. Only DIS but neither race nor the interaction was retained in the final model predicting abstinence; each unit increase in DIS was associated with 9% reduced odds of abstinence, OR: 0.91, 95% CI [0.87,0.96]. Findings point to the importance of examining factors associated with race that contribute to health inequities and underscore the need to consider how consequences of systemic racism, such as neighborhood context and other consequences not captured by the DIS, can constrain or facilitate smoking cessation when developing interventions. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Entities:  

Mesh:

Year:  2021        PMID: 34370500      PMCID: PMC8825869          DOI: 10.1037/pha0000493

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.492


  25 in total

1.  Racial residential segregation: a fundamental cause of racial disparities in health.

Authors:  D R Williams; C Collins
Journal:  Public Health Rep       Date:  2001 Sep-Oct       Impact factor: 2.792

2.  Neighborhood Disadvantage, Residential Stability, and Perceptions of Instrumental Support among New Mothers.

Authors:  Kristin Turney; Kristen Harknett
Journal:  J Fam Issues       Date:  2010-04

3.  Effectiveness of Switching Smoking-Cessation Medications Following Relapse.

Authors:  Bryan W Heckman; K Michael Cummings; Karin A Kasza; Ron Borland; Jessica L Burris; Geoffrey T Fong; Ann McNeill; Matthew J Carpenter
Journal:  Am J Prev Med       Date:  2017-03-20       Impact factor: 5.043

Review 4.  Differences in Quit Attempts and Cigarette Smoking Abstinence Between Whites and African Americans in the United States: Literature Review and Results From the International Tobacco Control US Survey.

Authors:  Jessica A Kulak; Monica E Cornelius; Geoffrey T Fong; Gary A Giovino
Journal:  Nicotine Tob Res       Date:  2016-04       Impact factor: 4.244

5.  Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study.

Authors:  Amy J H Kind; Steve Jencks; Jane Brock; Menggang Yu; Christie Bartels; William Ehlenbach; Caprice Greenberg; Maureen Smith
Journal:  Ann Intern Med       Date:  2014-12-02       Impact factor: 25.391

6.  Current Cigarette Smoking Among Adults - United States, 2005-2015.

Authors:  Ahmed Jamal; Brian A King; Linda J Neff; Jennifer Whitmill; Stephen D Babb; Corinne M Graffunder
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-11-11       Impact factor: 17.586

7.  Proactive tobacco cessation outreach to smokers of low socioeconomic status: a randomized clinical trial.

Authors:  Jennifer S Haas; Jeffrey A Linder; Elyse R Park; Irina Gonzalez; Nancy A Rigotti; Elissa V Klinger; Emily Z Kontos; Alan M Zaslavsky; Phyllis Brawarsky; Lucas X Marinacci; Stella St Hubert; Eric W Fleegler; David R Williams
Journal:  JAMA Intern Med       Date:  2015-02       Impact factor: 21.873

8.  Effect of varying levels of disease management on smoking cessation: a randomized trial.

Authors:  Edward F Ellerbeck; Jonathan D Mahnken; A Paula Cupertino; Lisa Sanderson Cox; K Allen Greiner; Laura M Mussulman; Niaman Nazir; Theresa I Shireman; Kenneth Resnicow; Jasjit S Ahluwalia
Journal:  Ann Intern Med       Date:  2009-04-07       Impact factor: 25.391

9.  Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.

Authors:  Timothy B Baker; Megan E Piper; James H Stein; Stevens S Smith; Daniel M Bolt; David L Fraser; Michael C Fiore
Journal:  JAMA       Date:  2016-01-26       Impact factor: 56.272

10.  A clinical trial to examine disparities in quitting between African-American and White adult smokers: Design, accrual, and baseline characteristics.

Authors:  Nicole L Nollen; Lisa Sanderson Cox; Qing Yu; Edward F Ellerbeck; Taneisha S Scheuermann; Neal L Benowitz; Rachel F Tyndale; Matthew S Mayo; Jasjit S Ahluwalia
Journal:  Contemp Clin Trials       Date:  2015-12-05       Impact factor: 2.226

View more
  1 in total

1.  Natural language signatures of psilocybin microdosing.

Authors:  Camila Sanz; Federico Cavanna; Stephanie Muller; Laura de la Fuente; Federico Zamberlan; Matías Palmucci; Lucie Janeckova; Martin Kuchar; Facundo Carrillo; Adolfo M García; Carla Pallavicini; Enzo Tagliazucchi
Journal:  Psychopharmacology (Berl)       Date:  2022-06-09       Impact factor: 4.415

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.